GABA (γ-amino butyric acid) is the major inhibitory transmitter in the central nervous system and its action is terminated by specific transporters (GAT), found in neurons and glial cells. We have previously described that GAT-3 is responsible for GABA uptake activity in cultured avian Müller cells and that it operates in a Na + and Cl − dependent manner. Here we show that glutamate decreases [ 3 H] GABA uptake in purified cultured glial cells up to 50%, without causing cell death. This effect is mediated by ionotropic glutamatergic receptors. Glutamate inhibition on GABA uptake is not reverted by inhibitors of protein kinase C or modified by agents that modulate cyclic AMP/PKA. Biotinylation experiments demonstrate that this reduction in GABA uptake correlates with a decrease in GAT-3 plasma membrane levels. Interestingly, both GAT-1 and GAT-3 mRNA levels are also decreased by glutamate. Conditioned media (CM) prepared from retinal neurons could also decrease GABA influx, and glutamate receptor antagonists (MK-801 + CNQX) were able to prevent this effect. However, glutamate levels in CM were not different from those found in fresh media, indicating that a glutamatergic co-agonist or modulator could be regulating GABA uptake by Müller cells in this scenario. In the whole avian retina, GAT-3 is present from embryonic day 5 (E5) increasing up to the end of embryonic development and post-hatch period exclusively in neuronal layers. However, this pattern may change in pathological conditions, which drive GAT-3 expression in Müller cells. Our data suggest that in purified cultures and upon extensive neuronal lesion in vivo, shown as a Brn3a reduced neuronal cells and an GFAP increased gliosis, Müller glia may change its capacity to take up GABA due to GAT-3 up regulation and suggests a regulatory interplay mediated by glutamate between neurons and glial cells in this process.
Introduction
Astroglial cells are in close contact with neurons in every compartment of the brain, and evidence indicates that secreted factors participate in a bidirectional communication throughout the nervous system, including the retina (de Melo . The concept of gliotransmitters refers to active molecules that modulate several neuronal functions, such as survival, differentiation and protection, and that are released by glial cells. In this sense, GABAergic synapses within the central nervous system (CNS) are constituted by a tripartite structure composed of a presynaptic neuron filled with vesicles containing neurotransmitter, a post-synaptic component with ionotropic GABAA (and GABAC in the retina) and/or metabotropic GABAB receptors and glial cells in a complex environment involved in GABAergic signaling. The removal and/or inactivation of GABAergic inhibitory signals depend largely on membrane transporters present not only in the presynaptic neuronal terminals or in the glial compartment, but also on ependymal and arachnoid cells (Eulenburg and Gomeza, 2010; Kanner, 2006) .
Thus far, several GABA transporters have been described (GAT1-4 and BGT) (Madsen et al., 2010; Wu et al., 2006) . All types are expressed in glial cells, with GAT-3 being the predominant glial isoform (reviewed in Schousboe, 2003) . The stoichiometry of operation of GABA transport via GAT1-4 requires 2Na + :1Cl − :1GABA whereas for BGT1 it requires 3Na + :2Cl − :1GABA (Karakossian et al., 2005; Loo et al., 2000) .
GAT-1 and GAT-3 transporters are found in the retina of several species, from skate (Birnbaum et al., 2005) to rodents (Brecha and Weigmann, 1994; Pow et al., 2005) , cat, monkey and human (Biedermann et al., 2002; Casini et al., 2006; Pow et al., 2005; Zhao et al., 2000) . It belongs to a subfamily of three high-affinity GABA transporters GAT1-3. GABA transporters expressed in neurons display a greater capacity of transport compared to glial transporters and are particularly related to the recycling of the neurotransmitter into GABAergic neurons. However, since GAT-1 is present in both neurons and glial cells, it is not possible to distinguish the exact role of glial and neuronal transporters. GABA is also taken up by astrocytes, where it can be degraded or converted into glutamine (Eulenburg and Gomeza, 2010) . In addition to their contribution to controlling neurotransmission and GABA synthesis in retinal cells (Calaza et al., 2001) , glial transporters can release GABA in a reversal mode of activity. This action is mediated by cell depolarization and might be important in conditions of low levels of the transmitter (Richerson and Wu, 2004) . Therefore, the regulation of GABA concentration in extra-synaptic sites due to the uptake by glial and neuronal transporters might exert a modulatory action on the overall activity of GABAergic synapses and constitutes a potential therapeutic target (Borden, 1996; Madsen et al., 2010; Schousboe, 2000) .
We have previously described that GAT-3 operates in avian Müller cells in culture in a Na + and Cl − dependent manner, inhibited by β-alanine and Zn
2+
, but not by NNC-711, a neuronal GAT-1 blocker. Here we have extended the previous reports showing that plastic changes in GAT-3 distribution can be observed when glia-neuron interactions are disrupted. A regulatory interplay, based on glutamatergic signaling, is presented as a possible factor able to modify GABA uptake in the context of gliosis, excitotoxicity and neuronal death. Fertilized white Leghorn eggs were purchased from a local hatchery. The embryos were staged according to Hamburger and Hamilton 1951 , and sacrificed by decapitation on embryonic day 9 (E9). The eyes were removed and the retinas were dissected out in a Ca 2+ -and Mg
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-free Hanks' (CMF) solution. The retinas were then used for culture preparations. We also used young chicks (up to 10 days) injected with NMDA in the right eye. All experiments involving animals were approved by the Animal Care and Use Committee of the Biophysics Institute (CEUA permit number IBCCF-035). Efforts were made to minimize animal suffering.
Retinal Müller glia
Retinal Müller glial cultures were generated from E9 chick retina essentially as described before (De Sampaio Schitine et al., 2007; Kubrusly et al., 2008; Reis et al., 2002) . Briefly, chick retina (0.25 retina per well) was dissociated using trypsin, and cells (neurons, glia and progenitors) were seeded over 6 well, 35 mm culture dishes in DMEM containing 10% FCS. After 10 days, cell cultures were incubated with 4 mM ascorbic acid for approximately 1.5 h to eliminate neurons, if necessary (Reis et al., 2002) . After this stage, only glia cells were found, this confirmed through immunocytochemistry analysis for glial or neuronal markers (not shown). Cultures were subsequently washed with DMEM, and purified glial cultures were obtained at E9C11-15 (cultures prepared from 9-day-old embryos maintained for 11-15 days in vitro).
GABA uptake by Müller glia
Glial cultures were rinsed with Hank's solution (128 mM NaCl, 4 mM KCl, 1 mM MgCl2, 3 mM CaCl2, 4 mM glucose, 20 mM HEPES) and subsequently incubated in Hank's solution with [
3 H] GABA (0.25 μCi/plate) and 100 μM GABA as substrate. The specific drugs used in the experiments were added 15 min before the [ 3 H] GABA incubation: PMA (0.1-2 μM), DHPG (10, 50 and 100 μM), MK801 (10 μM), DNQX (70 μM).
Live dead assay
A fluorescence-based viability assay was performed as instructed by the manufacturer (Live-dead assay; Invitrogen, Carlsbad, CA).
L-glutamate quantitation by HPLC-ED
Levels of L-glutamate in cultured cells and media were measured by high performance liquid chromatography coupled with electrochemical detection (HPLC-ED; Shimadzu, Japan) as described elsewhere (Monge-Acuña and Fornaguera-Trías, 2009). Briefly, samples were deproteinized with trichloroacetic acid (TCA; 10% w/v) and frozen at −70°C until further use. On the day of analysis, thawed samples were mixed with an o-phthalaldehyde-sulfite derivatizing solution (Rowley et al., 1995) and run through a C-18 reverse phase column (Sigma-Aldrich, USA) before detection.
Western blot
Western blotting was done as previously described (Pohl-Guimaraes et al., 2010) . Briefly, Müller glia cultures were washed twice in phosphate buffer saline (PBS), homogenized in the presence of protease inhibitors and subjected to sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE). The proteins were transferred to nitrocellulose membranes, briefly stained with Ponceau red, washed with an appropriate buffer and pre-incubated with 5% casein and 1% bovine serum albumin (BSA) for 2 h at room temperature in a shaker. The membranes were rinsed with Trisbuffered saline containing Tween and incubated with the primary antibodies against the GABA transporter GAT-3 (1:500) at 4°C overnight under agitation. Secondary horseradish peroxidase (HRP)-conjugated antibodies (Sigma) were used to develop the protein band corresponding to each of the expected molecular weights of the proteins of interest, using ECL-plus (Pharmacia-Amersham).
Eye injections
Ten days post-hatched chicken was used to perform the in vivo assays. The animals were injected with 5 μl of 50 mM NMDA in the right eye while the animal received an injection of sterile PBS at the same amount in the left eye. The animals were kept under normal light cycle for 15 days and then sacrificed, by decapitation and the eyes were removed.
Tissue fixation
Immediately after enucleation, the eyes were cut perpendicularly, in order to form eye cups. After that, the eyes cups were fixed by immersion in 4% paraformaldehyde (PA) in 0.16 M phosphate buffer (PB), pH 7.2, for 2 hours. Eyes cups were then rinsed with PB, and then cryoprotected in sucrose (15 and 30%). After 24 hours, the eyes cups were mounted in OCT embedding medium (Sakura Finetek, Torrance, CA), frozen and cryosectioned. Retina sections of 12-16 μm were collected on poli-l-lysine (Sigma) pre-treated slides.
Immunocytochemistry
Immunofluorescence was carried out as previously described (Calaza et al., 2001; Kubrusly et al., 2008) . Briefly, Müller cell cultures were rinsed in phosphate buffer saline (PBS, CaCl2 = 0.680 mM, KCl = 2.7 mM, KH2PO4 = 1.47 mM, MgSO4 = 0.49 mM, NaCl = 136 mM, Na2HPO4 8 mM, pH 7.4) twice and then fixed in 4% paraformaldehyde (PA) in 0.16 M phosphate buffer, pH 7.2, for 10 min. The cultures were then rinsed 3 times with PBS and pre-incubated with 3% bovine serum albumin (BSA) and 0.25% Triton for 30 min. Primary antibodies for immunofluorescence were incubated overnight in the same blocking solution followed by a 2 h incubation with secondary antibodies. Primary antibodies were primary mouse monoclonal antibody (IgG) reacting with chicken retina-2M6 (Müller glia cell-specific antigen) diluted 1:500, a rabbit antibody against GAT-3 (Millipore) diluted 1:200, a rabbit antibody against GFAP (Spring, M3782) diluted 1:100 and a primary mouse monoclonal antibody (IgG) reacting with Brn3a. Secondary antibodies were goat antimouse Alexa 488 and goat anti-mouse Alexa 555 (Invitrogen). Cultured cells were counterstained with DAPI (4′-6-diamino-2 phenylindole) (Sigma) as a nucleic acid stain (1 μg/ml). Further washes in PBS were made and finally slides were mounted in sodium n-propyl-gallate 0.2 M pH 7.2 in glycerol. Immunohistochemistry was performed on slides with sections of control and experimental retinas. The slides were first washed in sodium phosphatebuffered saline (PBS). Then the tissue was pre-incubated with 5% normal goat serum for 30 minutes, followed by overnight incubation with primary antibodies against GAT3 polyclonal rabbit antiserum (1:100, Millipore) or monoclonal anti-2M6 (kindly provided by Dr. B. Schlosshauer; Max-Planck-Institute, Tübingen, Germany). After several rinses in PBS, the sections were incubated for 2 hours at room temperature with the appropriate secondary antibodies as follows: donkey anti-mouse Alexa Fluor 488 antibody, anti-rabbit Alexa Fluor 594 (all 1:400 and all from Invitrogen).
RNA extraction and qRT-PCR
Total RNA was extracted from cells using the Trizol method. Realtime quantitative reverse transcription-PCR (qRT-PCR) was performed in one-step with 100 ng of total RNA and using the KAPA SYBR Fast One
Step qRT-PCR system (KAPA BIOSYSTEMS KK4650) and using the Step One Plus Real Time PCR System (Applied Biosystems). The qPCR profile consisted of an initial cDNA synthesis at 42°C for 5 min and 95°C for 5 min; then followed by 40 cycles of 95°C for 3 s and 60°C for 30 s. A melt curve stage was added. We used the following specific primers to amplify: chGat1F 5′-ATCCCTATGTTATGCTGCTTATCT-3′ and chGat1R 5′-CATCTAGCCAAACCTCAGAGT-3′. chGat 3F 5′-CTGGGTTTATGGC AGCAATC-3′ and chGat3R 5′-GCACAAATACCTGGAGTTATGAC-3′. S17 chick ribosomal protein messenger RNA was used as an internal control. The oligonucleotides used were: S17F 5′-CCGCTGGATGCGCTTCATCAG-3′ and S17R 5′-TACACCCGTCTGGGCAAC-3′. PCR products were sequenced in order to verify their identity. The relative abundance of GAT1 or GAT3 mRNA is expressed as sample versus a control in comparison to S17 chick ribosomal mRNA and was calculated using the 2 −ΔΔCT .
Surface biotinylation and western blotting
To determine plasma membrane expression of the GAT3 protein, a 100 mm culture dish was used for each experimental condition (n = 3). After treatment, one wash with 3 ml of ice-cold PBS, pH 8, was performed; Müller glia monolayers were incubated in 3 ml of EZ-Link Sulfo-NHS-LC-Biotin (0.14 mg/ml or 0.25 mM) solution in PBS Ca 2+ , Mg 2+ , for 30 min in gently agitation at 4°C. The reagent was removed by washing the culture plates 3 times with 3 ml of ice-cold 0.1 M L-glycine PBS, pH 8.0 with slow agitation. Subsequently, the cells were scraped and lysed in approximately three times the pellet volume with lysis buffer (50 mM Tris-acetate buffer, 5 mM EDTA, pH 7, 0.3% (v/v) SDS, 0.3% (v/v) Triton X-100), the homogenization was carried out with a sonic dismembrator (Cat. FB50 Fisher Scientific) using three 15 amplitude pulses on ice. The lysate was centrifuged at top speed in a tabletop centrifuge for 5 min at 4°C, and the protein concentration of the supernatant was measured by the Bradford microplate assay. At least 500 μg of protein was mixed with 30 μl of avidin-coated agarose particles. The suspension was incubated at 4°C overnight with slight agitation. The first supernatant was separated and used for non-biotinylated intracellular proteins and after that the agarose particles were washed 3 times with 0.5 ml of 0.1% (v/v) Triton X-100 PBS, and centrifuged at 14,000× g for 4 min at 4°C and the pellet was resuspended in 10 μl of SDS-PAGE sample buffer. Samples were boiled for 5 min and the same quantities of protein for input and supernatants and the whole pellet of biotinylated proteins were loaded in the gels.
Single cell calcium imaging
Variations in the free intracellular calcium level ([Ca 2+ ]i) were evaluated in Müller cells following an adaptation of the protocol reported by de Melo Reis et al. (2011) and essentially described for DRG neurons and Schwann cells (Ribeiro-Resende et al., 2014) . The cells were loaded for 40 min with 5 μM Fura-2/AM (Molecular Probes) in Krebs solution (132 mM NaCl, 4 mM KCl, 1.4 mM MgCl2, 2.5 mM CaCl2, 6 mM glucose, 10 mM HEPES, pH 7.4) containing 0.1% fatty acid-free bovine serum albumin (BSA) and 0.02% pluronic acid F-127 (Molecular Probes) in an incubator containing 5% CO2 and 95% atmospheric air at 37°C. To obtain a complete hydrolysis of the probe, cells rested at room temperature for 10 min in Krebs solution. The 15 mm glass coverslip (Marienfeld, Germany) containing the cells was mounted on an RC-20 chamber in a P-5 platform (Warner Instruments, Hamden, CT) on the stage of an inverted fluorescence microscope (Eclipse Ti-U; Nikon). The cells were continuously perfused with Krebs solution and stimulated with 2 mM glutamate. Solutions were added to the cells by a gravity perfusion system, including a set of syringes and a rotary selector valve. The variations in [Ca2+]i were evaluated at intervals of 500 ms, by quantifying the ratio of the fluorescence emitted at 510 nm following alternate excitation at 340 and 380 nm, using a Lambda DG4 illumination system (Sutter Instrument, Novato, CA), a 40× objective and a 510 nm bandpass filter (Semrock, Rochester, NY) before fluorescence acquisition with a 16-bit cooled EMCCD camera (Photometrics, Tuscon, AZ). Acquired values were processed using MetaFluor software (Molecular Devices, Sunnyvale, CA). Values for Fura-2 fluorescence ratio were calculated based on a threshold of 20% increase in the [Ca2+]i level induced by the stimulus.
Data analysis
Statistical analysis was performed (Prism 6) using Student's t test or analysis of variance (ANOVA) followed by post hoc Tukey's test for multiple comparisons, or Dunnett's multiple comparison posthoc test. Statistical significance was taken at p < 0.05. Unless specified otherwise, the results are expressed as mean ± standard error (SEM) of at least three separate experiments performed in triplicate. (De Sampaio Schitine et al., 2007) . Therefore, we investigated which factors could be involved in this effect. We asked if glutamate, a major excitatory amino acid present in retinal neurons, could be that factor. Indeed, addition of glutamate at a 2 mM concentration to purified cultured Müller cells reduced by 50% [ 3 H] GABA uptake (Fig. 1A) . Moreover, when Müller cultures were pre-incubated in CM containing 10 μM MK801, a non-competitive NMDA receptors antagonist, plus 70 μM DNQX (a competitive non-NMDA receptors antagonist), the inhibition of [ 3 H] GABA uptake observed with CM was no longer present (Fig. 1A) . In order to investigate if a strong membrane depolarization could induce a similar effect in Müller cells, we exposed the cells to 80 mM KCl. As depicted in Fig. 1B, [ 3 H] GABA uptake was reduced mimicking the CM and glutamate effects. Moreover, this effect was completely inhibited in the presence of MK801 and DNQX (Fig. 1B) .
Results
[
We measured the glutamate contents in CM, by high performance liquid chromatography-electrochemical detection (HPLC-ED). Glutamate concentration was found to be similar to the concentration found in fresh media (Fig. 1C) . Therefore, the decrease in [ uptake induced by CM was related to additional factors other than glutamate.
We performed calcium imaging in purified Müller cells. As shown in Fig. 1D , Müller glia cells plated on a 15 mm glass coverslip were loaded with fura-2 AM, washed with Krebs solution and selected (colored circles); typical responses are shown for 30 cells when stimulated with 2 mM glutamate for 1 minute (arrow, Fig. 1E ). Essentially, all Müller glia cells were responsive to glutamate. In order to rule out that the decrease in GABA uptake by glutamate could be related to membrane dysfunction by cytotoxicity, we performed a live dead assay in Müller glia cells in the presence of 1-2 mM glutamate or 0.1% H2O2. As shown (Fig. 1F) , while glutamate was not excitotoxic to Müller cells compared to control levels, H2O2 completely eliminated Müllerglia after 30 min incubation.
In order to characterize the glutamatergic receptors involved in this effect, we performed dose-response curves for glutamate ( Fig. 2A) , NMDA (Fig. 2D) or kainate (Fig. 2C) , 1993; Reis et al., 1995) . The apparent IC50 for glutamate inhibition of GABA uptake was above 1 mM, possibly reflecting effective removal of glutamate by the glial cells. In addition, the effect of glutamate in reducing [ 3 H] GABA uptake was time-dependent and inhibition could be observed after a 10 min of incubation, and remained constant for up to 24 hrs (Fig. 2B) . Addition of 3,5 dihydroxyphenylglycine (DHPG 0.05-0.1 mM), a metabotropic group I glutamate receptor agonist, had no effect on [ 3 H] GABA uptake (Fig. 2F) .
Protein kinase C (PKC) has been reported to phosphorylate GAT 1 in hippocampal cells (Beckman et al., 1999) . Therefore, we decided to expose Müller cells to phorbol myristate acetate (PMA), a PKC activator. The results, shown in Fig. 3A , reveal an inhibition of [ 3 H] GABA uptake in the presence of PMA, with an IC50 value of approximately 300 nM. However, addition of PKC inhibitors (100-500 nM staurosporine, 100 nM Calphostin C or 1 μM Ro 32-0432) in the presence of 2 mM glutamate did not revert the decrease in [ 3 H] GABA uptake (Fig. 3B) . A fourth inhibitor was also used (0.1 μM bisindolylmaleimide I (BIS I), and no effect was seen in the presence of glutamate, not shown). Therefore, glutamate is not operating on GAT-3 transporter through PKC. Protein kinase A (PKA) has also been reported to modulate the function of GABA transporters in the avian retina . Indeed, Müller glia show functional D1 dopamine and PACAP receptors that increase cyclic AMP (Kubrusly et al., 2005) . Therefore, we asked if forskolin, dopamine or PACAP agonists could revert the glutamate inhibition in [ 3 H] GABA uptake. As shown in Fig. 3C , none of these compounds had an effect in cultured Müller glia in the presence of 2 mM glutamate. It was also recently reported that glutamate and ATP could have interplay in terms of neuronal death via P2X7 in mixed Müller glia-neuronal cultures from chick embryos (Anccasi et al., 2013) , as this effect was inhibited by glutamatergic antagonists (MK-801 and DNQX). Therefore we asked if glutamate inhibition on [ 3 H] GABA release could be mediated by Ca 2+ entry induced by ATP on P2X7 receptors. As shown in Fig. 3D , 0.01-1 mM ATP or 100 nM brilliant blue G (BBG, a P2X7 inhibitor) had no effect on the inhibitory action of glutamate upon GABA uptake in purified Müller cells (Fig. 3D) .
The results described thus far raised the question of whether the inhibition of [ 3 H] GABA uptake was due to a modification in the GAT-3 activity, or a change in the number of transporters in the cell membrane. To answer this question, we performed a biotinylation assay for GAT-3 (see Section 2) in Müller glia cells under stimulation with glutamate for 30 min. As shown in Fig. 4 , 2 mM glutamate decreases the amount of plasma membrane GAT-3 levels when compared to the non-stimulated condition.
In order to evaluate if glutamate also decreased the amount of GAT-3 and GAT-1 mRNA levels, Müller glial cells were treated for 2 h with a fixed 2 mM glutamate concentration. qRT-PCR analysis showed that glutamate acting through N-methyl-D-aspartate (NMDA) as well as non-NMDA ionotropic receptors reduce both GABA transporter mRNA levels (Fig. 5) . As shown, TPA (a PMA analog) also decreased the amount of GAT-3 and GAT-1 mRNA levels in Müller glial cells. Together, these data point out that glutamate operates at the transcriptional and post-translational levels decreasing the amount of GAT-3 transporters, and therefore GABA uptake in Müller glia cells.
Although both GAT-3 and GAT-1 transporters are expressed in Müller glia cells, only GAT-3 is responsible for the [ 3 H] GABA uptake activity in purified glial cultures (De Sampaio Schitine et al., 2007) . Western blot analysis, using a specific antibody against GAT-3, revealed that GAT-3 expression increases during retinal development. It is first detected at embryonic days 5-7 with a molecular weight around 66 kDa, as shown for purified Müller glia (De Sampaio Schitine et al., 2007) . The intensity of the GAT-3 band increases around E9 and E11 (Fig. 6) . At E16 and in post-embryonic retinas, the transporter is highly expressed (Fig. 6) .
We finally evaluated the GAT-3 immunoreactivity pattern in the adult chick retina. As shown in Fig. 7A , GAT-3 (red) is heavily expressed in the inner plexiform layer (IPL) and in some cell bodies . Forskolin, dopamine or PACAP, agents that increase cyclic AMP and activate PKA in Müller glia cells had no effect in the [ 3 H] GABA uptake presence of 2 mM glutamate (3C). Addition of 0.01-1 mM ATP or 100 nM brilliant blue G (BBG, a P2X7 inhibitor) had no effect on the inhibitory action of glutamate upon GABA uptake in purified Müller cells (D) . N = 3 experiments performed in triplicate or quadruplicate; for Calphostin C (n = 4). *p < 0.05.
in the inner nuclear layer (INL) where most of the amacrine cells are located. In the control retina, no co-localization was observed between GAT-3 (red) and the selective Müller glial marker 2M6 (green, Schlosshauer et al., 1991) . A well-known protocol to induce retinal neurodegeneration was then applied (Fischer and Reh, 2001 ). After 15 days of the intraocular injection of NMDA (2 μmol) in the right eye, the neurodegeneration described by Fischer and Reh (2001) was confirmed by the decrease in the retinal layers thickness, observed with DAPI staining (Fig. 7B) . After the retinal cell death, a completely different pattern of GAT-3 and 2M6 expression appeared ( Fig. 7B and inset) . In this pathological condition, 2M6-positive radial fibers were more frequently seen, and a substantial expression of GAT-3 was now observed co-localizing with 2M6-positive Müller end-feet near the ganglion cell layer (Fig. 7B and  inset) . Indeed, the reduction in the number of positive cells for a ganglion cell marker (Brn3a) in the ganglion cell layer (Fig. 7D) is evident compared to the control retina (Fig. 7C) . These results suggest a GAT-3 up regulation in Müller cells, probably because of reactive gliosis as shown for GFAP expression in the lesioned retina (Fig. 7F ) induced by neurodegeneration, compared to the control retina (Fig. 7E) . Interestingly, spots of GAT-3 transporter are also seen at the membrane of purified Müller glia cells in culture 2 weeks after plating (Fig. 7G ).
Discussion
Müller cells in the retina completely surround glutamatergic and GABAergic synapses (Boulland et al., 2002) , suggesting their involvement in the turnover of these transmitters in this structure. In this report, we demonstrate that glutamate, acting through its ionotropic receptors, is involved in the regulation of glial GABA transporters. A sharp decrease in [ . Glutamate reduces GAT mRNA levels. Cultured Müller cells were treated with glutamate (2 mM, 2 h) or TPA (1 μM, 2 h). Addition of glutamatergic ionotropic receptor antagonists (MK801, 10 μM and CNQX 100 μM) was performed 30 min before the glutamate treatment and cells were harvested 4 h and 8 h after treatment to analyze GAT3 and 1, mRNA levels. Data were normalized against S17 ribosomal mRNA expression. Data are shown as the mean ± standard error; statistical analysis was performed by ANOVA and Dunn test. **P < 0.01, ***P < 0.001. (Loiola and Ventura, 2011) .
The high glutamate concentration (above 1 mM) needed to inhibit GABA transport might be related to expression of functional glutamate transporters in Müller cells (Gadea et al., 2004) . In fact, when selective and non-transportable agonists were used to mimic the effect of glutamate, a low EC50 was shown for NMDA and kainate (≅30 μM) (Fig. 2) reinforcing our interpretation. We show that the decrease in GABA uptake by glutamate is not due to membrane dysfunction induced by cytotoxicity, as 2 mM glutamate had no toxic effects to Müller cells compared to control levels. In addition, previous data from our lab indicate that kainate at 150 μM (that decreases GAT-3 transporters from Müller glia cells, shown in Fig. 2 ) has no effect in the choline transporter from mixed neuronal-Müller glia cells in culture measured in terms of [ 3 H] choline uptake (Loureiro-dos-Santos et al., 2001) . Also, glutamate stimulates the ascorbate transporter system in the chick retina (Portugal et al., 2009 ) in a DNQX, but not MK801 dependent manner. Therefore, the effect of glutamate in GAT-3 in Müller cells from the chick retina is not due to non-specific membrane dysfunction. Finally, the contents of glutamate in the CM are not different from the one found in DMEM-F12. This suggests that additional factors present in the CM could release glutamate from Müller glia that would decrease GABA uptake. Indeed, neuronal CM loses its capacity to reduce GABA uptake in the presence of NMDA (MK-801) or non-NMDA (DNQX) antagonists (Fig. 1) . One such factor could be D-serine, shown to be released from the vertebrate retina that activates NMDA receptors (Gustafson et al., 2014) .
It has been shown that the Müller cells are the major supportive glia for neurons in the adult retina. After a widespread neuronal degeneration induced with intraocular injection of NMDA in the chick retina (Fischer and Reh, 2001 ), Müller cells re-enter the cell cycle and behave like progenitors, giving rise to new cells. Moreover, it was found that the mammalian retina also has potential to regenerate inner retinal neurons in vivo from Müller glia (Karl et al., 2008) .
Previous data from our lab have shown that Müller cells are neurochemically plastic. Cultured Müller cells express neuronal markers such D1A and D1B dopamine receptors under conditions in which neurons are eliminated (Kubrusly et al., 2005) . Müller glia cells also express tyrosine hydroxylase and L-dopa decarboxylase, enzymes involved in dopaminergic transmission (Kubrusly et al., 2005) . Due to the acquisition of dopaminergic function, these cells have recently been used for cell therapy in a mouse model of Parkinson disease . These data suggest a complex neuronglia signaling that regulates the differentiated phenotype of the Müller cells, especially the expression of proteins associated with the dopaminergic machinery (Kubrusly et al., 2008; Reis et al., 2007) . Based on this scenario, we show in the present work that Müller glia also change their standard features related to the GABAergic system.
As opposed to mammalian retina (Andrade da Costa et al., 2000) , Müller glia from the chick retina cannot take up GABA (Calaza et al., 2001; Marshall and Voaden, 1974) . Cultured Müller glia from the chick retina express both GAT-1 and GAT-3, but only GAT-3 seems to be active as based on pharmacological evidence (De Sampaio Schitine et al., 2007) . Reactive gliosis is an important event after lesion in the nervous system, particularly in the retina (Bringmann et al., 2009; Fischer and Reh, 2001) . Even though chicken Müller cells do not take up GABA in vivo, in the absence of neurons, these cells are capable to take up the neurotransmitter, suggesting the existence of neuronglia communication that halts in situ glial GABA uptake activity.
It has been described that GAT-1 is subject to multiple forms of regulation, via second messengers and protein-protein interactions (Hu and Quick, 2008) . The various forms of regulation include plasma membrane transporter translocation rates. In this context, PKC is associated with a decrease in GAT1 transport capacity and an accumulation of the protein in the intracellular compartment (Beckman et al., 1999) . Interestingly it is known that through the use of selective muscarinic agonist receptors for M1, M3 and M5 subtype family, a decrease in GABA uptake activity in hippocampus is present, and that this effect is related to a decrease in the cell surface expression of GAT-1 shown through protein biotinylation, through the involvement of PKC (Beckman et al., 1999) . In the present communication, glutamate decreases GAT-3 at the cell surface, with the expected increase in the supernatant fraction (Fig. 4) .
Glutamate also modulates GAT-1 activity through metabotropic receptors. Treatment of hippocampal rat cultures with trans-ACPD or DHPG, which are specific agonists for group 1 metabotropic receptors, decreases GAT -1 function (Beckman et al., 1999) . Although Müller cells express group I metabotropic glutamate receptors (Ji et al., 2012) , no effect in the decrease in GABA uptake promoted by glutamate could be detected. In addition, PMA decreased [ 3 H] GABA uptake in a dose-dependent manner in Müller cells. However, the effect of glutamate inhibition on [ 3 H] GABA uptake was independent of PKC, based on three different selective inhibitors (Fig. 3) . Also, a fourth inhibitor (BIS I) had no effect on the effect promoted by glutamate on GAT-1 and GAT-3 mRNA (not shown).
Previous data from our lab have shown that Müller cells are neurochemically plastic. Cultured Müller cells express neuronal markers such D1A and D1B dopamine and PACAP receptors under conditions in which neurons are eliminated (Kubrusly et al., 2005) . As these receptors increase cAMP, we asked if cAMP/PKA could operate on [ 3 H] GABA uptake, but there was no effect in the presence of forskolin, PACAP, SKF (a D1 receptor agonist) reverting the inhibition promoted by glutamate.
More subtle interactions between glutamate and glial GABA transport had been considered in other regions of the brain balancing excitatory and inhibitory signals in slice preparations from the hippocampus (Héja et al., 2012) , cerebral cortex (Unichenko et al., 2013) , and striatum (Wójtowicz et al., 2013) . Here, we show that glutamate reduces GAT-3 and GAT-1 mRNAs in purified Müller glia via ionotropic glutamate receptors (Fig. 5) .
It was reported that glutamate intermediates neuronal death via P2X7 in mixed Müller glia-neuronal cultures from chick embryos. This effect was inhibited by glutamatergic antagonists (MK-801 and DNQX). Moreover, [ 3 H]-D-aspartate (a glutamate analog) uptake is reduced by ATP in cultured glial cells (Anccasi et al., 2013) . Although ATP activates P2X7 receptors in the millimolar range in a Ca 2+ dependent manner in macrophages, neurons or astrocytes (Alves et al., 2014) , addition of this nucleotide had no effect on the glutamate inhibition of [ 3 H] GABA uptake (Fig. 3D) . In addition, 100 nM brilliant blue G (BBG) had no effect on the glutamatergic inhibition.
Even though GAT-3 is detected in the avian retina during development and in the mature retina, immunoreactivity for this transporter has not been detected in Müller cells in the intact tissue, as measured by its co-localization with 2M6, a Müller specific antigen. However, lesion of retinal neurons promotes an impressive increase in GAT-3 immunoreactivity in Müller fibers. This phenomenon is likely due to the interruption of proper interaction of retina neurons with the Müller system, as clearly observed with the purified Müller cell model described earlier. Indeed, Brn3a labeling identifies a loss of RGCs in the retina injected with NMDA (Fig. 7D) , followed by an increase in the contents of GFAP (Fig. 7F) . Therefore, any in vivo lesions (for instance, in ischemia) may in fact be potentiated by decreased inhibitory tonus caused by increased GABA uptake by Müller cells. It would be interesting to consider, pharmacological interventions that could reduce GABA uptake and improve the inhibitory strength, in lesioned areas, with the purpose of reducing excitotoxicity. The avian retina system seems to be a good model to approach these concepts. Experiments currently in progress in our labs are aimed at characterizing the molecular mechanisms involved in glutamate-dependent GAT-3 plasma membrane level reduction.
